IGF2 and ovarian carcinoma: IGF-II-signaling pathway: Sakurai M et al. [63] found that despite its high expression in the ovarian clear cell carcinoma (CCC) subtype of ovarian cancer, GPC3 knockdown in CCC cells promoted cell proliferation via enhancing IGF-II-mediated activation of the PI3K/Akt pathway.